About this trial
Emergence agitation is a clinical condition in which the child experiences a variety of behavioural disturbances including crying, thrashing, and disorientation during early awakening from anaesthesia. Emergence agitation is a common challenge in children with a reported incidence of approximately 25% ranging from 10 to 80 %. Clonidine is often used off-label in paediatric anaesthesia e.g. sedation in the intensive care unit, prevention of withdrawal symptoms after long-term sedation, as premedication before induction of anaesthesia or as treatment/prevention of emergence agitation. The study is designed as a randomised, placebo-controlled clinical trial evaluating efficacy and safety of a single dose of intraoperative clonidine in children 3-12 months, including pharmacokinetics.
Eligibility criteria
Qualifiers
Paediatric patients (male and female), aged 3- ≤ 12 months
Scheduled general anaesthesia with sevoflurane and opioid. Induction with propofol is optional
The legally acceptable representative for the study participant provides written informed consent/assent for the trial
Disqualifiers
ASA >2
Cardiac, neuro and trauma surgery
Ex-premature (<37 weeks) • Premedication with clonidine
Intubated prior to scheduled anaesthesia or is expected to require intubation after the procedure
Trial design
Treatments tested in this trial
- Clonidine
- Sodium chloride